Ceramides are associated with inflammatory processes in human mediastinal adipose tissue

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 2, 2014, Pages 124-131

  Gertow, J ^a   Kjellqvist, S ^a   Stahlman M ^b   Cheung, L ^a   Gottfries, J ^c   Werngren, O ^a   Boren J ^b   Franco Cereceda, A ^a   Eriksson, P ^a   Fisher, R M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Adipose tissue; Ceramide; Inflammation

Indexed keywords

ALKALINE CERAMIDASE; C REACTIVE PROTEIN; CERAMIDE; CERAMIDE GLUCOSYLTRANSFERASE; CERAMIDE KINASE; GLUCOSE TRANSPORTER; GLYCOSYLTRANSFERASE; NEUTRAL CERAMIDASE; SERINE PALMITOYLTRANSFERASE; SPHINGOSINE KINASE;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MEDIASTINUM; MICROARRAY ANALYSIS; MIDDLE AGED; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; CERAMIDE; INFLAMMATION;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; CERAMIDES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVERWEIGHT; REPRODUCIBILITY OF RESULTS;

EID: 84894234522     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2013.05.004     Document Type: Article

References (30)

1. Frederiksen L., Nielsen T.L., Wraae K., Hagen C., Frystyk J., Flyvbjerg A., et al. Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men. J Clin Endocrinol Metab 2009, 94:4010-4015.
2. Ibrahim M.M. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 2010, 11:11-18.
3. Thanassoulis G., Massaro J.M., Hoffmann U., Mahabadi A.A., Vasan R.S., O'Donnell C.J., et al. Prevalence, distribution, and risk factor correlates of high pericardial and intrathoracic fat depots in the Framingham heart study. Circ Cardiovasc Imaging 2010, 3:559-566.
4. Rosito G.A., Massaro J.M., Hoffmann U., Ruberg F.L., Mahabadi A.A., Vasan R.S., et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008, 117:605-613.
5. Sironi A.M., Petz R., De Marchi D., Buzzigoli E., Ciociaro D., Positano V., et al. Impact of increased visceral and cardiac fat on cardiometabolic risk and disease. Diabet Med 2012, 29:622-627.
6. Felber J.P., Golay A., Jequier E., Curchod B., Temler E., DeFronzo R.A., et al. The metabolic consequences of long-term human obesity. Int J Obes 1988, 12:377-389.
7. Summers S.A. Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 2006, 45:42-72.
8. Promrat K., Longato L., Wands J.R., de la Monte S.M. Weight loss amelioration of non-alcoholic steatohepatitis linked to shifts in hepatic ceramide expression and serum ceramide levels. Hepatol Res 2011, 41:754-762.
9. Haus J.M., Kashyap S.R., Kasumov T., Zhang R., Kelly K.R., Defronzo R.A., et al. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 2009, 58:337-343.
10. Adams J.M., Pratipanawatr T., Berria R., Wang E., DeFronzo R.A., Sullards M.C., et al. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 2004, 53:25-31.
11. Kotronen A., Seppanen-Laakso T., Westerbacka J., Kiviluoto T., Arola J., Ruskeepaa A.L., et al. Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum. Obes (Silver Spring) 2010, 18:937-944.
12. Kolak M., Westerbacka J., Velagapudi V.R., Wagsater D., Yetukuri L., Makkonen J., et al. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 2007, 56:1960-1968.
13. Blachnio-Zabielska A.U., Baranowski M., Hirnle T., Zabielski P., Lewczuk A., Dmitruk I., et al. Increased bioactive lipids content in human subcutaneous and epicardial fat tissue correlates with insulin resistance. Lipids 2012, 47:1131-1141.
14. Blachnio-Zabielska A.U., Pulka M., Baranowski M., Nikolajuk A., Zabielski P., Gorska M., et al. Ceramide metabolism is affected by obesity and diabetes in human adipose tissue. J Cell Physiol 2012, 227:550-557.
15. Blachnio-Zabielska A.U., Koutsari C., Tchkonia T., Jensen M.D. Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance. Obesity (Silver Spring) 2012, 20:2341-2347.
16. Menuz V., Howell K.S., Gentina S., Epstein S., Riezman I., Fornallaz-Mulhauser M., et al. Protection of C. elegans from anoxia by HYL-2 ceramide synthase. Science 2009, 324:381-384.
17. Huang H., Kasumov T., Gatmaitan P., Heneghan H.M., Kashyap S.R., Schauer P.R., et al. Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients. Obesity (Silver Spring) 2011, 19:2235-2240.
18. Fabrias G., Munoz-Olaya J., Cingolani F., Signorelli P., Casas J., Gagliostro V., et al. Dihydroceramide desaturase and dihydrosphingolipids: debutant players in the sphingolipid arena. Prog Lipid Res 2012, 51:82-94.
19. Stiban J., Fistere D., Colombini M. Dihydroceramide hinders ceramide channel formation: implications on apoptosis. Apoptosis 2006, 11:773-780.
20. Signorelli P., Munoz-Olaya J.M., Gagliostro V., Casas J., Ghidoni R., Fabrias G. Dihydroceramide intracellular increase in response to resveratrol treatment mediates autophagy in gastric cancer cells. Cancer Lett 2009, 282:238-243.
21. Teichgraber V., Ulrich M., Endlich N., Riethmuller J., Wilker B., De Oliveira-Munding C.C., et al. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 2008, 14:382-391.
22. Yang G., Badeanlou L., Bielawski J., Roberts A.J., Hannun Y.A., Samad F. Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. Am J Physiol Endocrinol Metab 2009, 297:E211-E224.
23. Kolak M., Gertow J., Westerbacka J., Summers S.A., Liska J., Franco-Cereceda A., et al. Expression of ceramide-metabolising enzymes in subcutaneous and intra-abdominal human adipose tissue. Lipids Health Dis 2012, 11:115.
24. Luan Y., Griffiths H.R. Ceramides reduce CD36 cell surface expression and oxidised LDL uptake by monocytes and macrophages. Arch Biochem Biophys 2006, 450:89-99.
25. Summers S.A., Garza L.A., Zhou H., Birnbaum M.J. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol Cell Biol 1998, 18:5457-5464.
26. Holland W.L., Brozinick J.T., Wang L.P., Hawkins E.D., Sargent K.M., Liu Y., et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 2007, 5:167-179.
27. Iacobellis G., Corradi D., Sharma A.M. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005, 2:536-543.
28. Atalar F., Gormez S., Caynak B., Akan G., Tanriverdi G., Bilgic-Gazioglu S., et al. Mediastinal adipose tissue expresses a pathogenic profile of 11 beta-hydroxysteroid dehydrogenase Type 1, glucocorticoid receptor, and CD68 in patients with coronary artery disease. Cardiovasc Pathol 2012, [Epub 03.09.12 ahead of print]. 10.1016/j.carpath.2012.07.006.
29. Spiegel S., Cuvillier O., Edsall L., Kohama T., Menzeleev R., Olivera A., et al. Roles of sphingosine-1-phosphate in cell growth, differentiation, and death. Biochemistry (Mosc) 1998, 63:69-73.
30. Curat C.A., Wegner V., Sengenes C., Miranville A., Tonus C., Busse R., et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006, 49:744-747.